Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India · Delayed Price · Currency is INR 2,935.70
+141.90 (5.08%)
Sep 24, 2026, 10:20 AM IST
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 212.17 billion as of September 23, 2026. Its market cap has increased by 19.05% in one year.
Market Cap
212.17B
Enterprise Value
203.34B
Revenue
22.87B
Ranking
n/a
PE Ratio
31.89
Stock Price
2,935.70
ChartMarket Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 212.17B, an increase of 3,789,352.53%. That is a compound annual growth rate of 53.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 211.26B | 50.95% |
| Dec 31, 2025 | 139.95B | -26.39% |
| Dec 31, 2024 | 190.12B | 84.60% |
| Dec 29, 2023 | 102.99B | 90.47% |
| Dec 30, 2022 | 54.07B | -16.82% |
| Dec 31, 2021 | 65.01B | 69.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 381.12B |
| Wockhardt | 355.42B |
| Piramal Pharma | 285.34B |
| Eris Lifesciences | 179.49B |
| Cohance Lifesciences | 176.15B |
| Alivus Life Sciences | 171.88B |
| Alembic Pharmaceuticals | 166.83B |
| NATCO Pharma | 146.21B |